FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2594150853> ?p ?o ?g. }

• W2594150853 abstract "The high attrition rates observed in cancer drug discovery (up to 95% of failure of drugs tested in phase I trials) have raised the awareness of the scientific and industrial communities towards the need for more predictive pre-clinical models. These models should be more representative of the disease and consequently help to eliminate at pre-clinical stages drug candidates that lack efficacy or safety. Tumor microenvironment is composed by a network of fibroblasts, endothelial cells, immune-competent cells within the extracellular matrix (ECM). Interactions between these components are critical for tumor initiation, proliferation, migration and metastasis. The design of in vitro cancer cell models that recapitulate the tumor microenvironment and 3D architecture provides higher physiological relevance as they more closely resemble the in vivo cellular context. We have established methodologies for scalable generation of 3D cancer cell models in stirred-tank culture systems, and applied these to a large panel of tumor cell lines from different pathologies, including breast, colon, hepatic and lung tumor cell lines. Large numbers of spheroids were obtained per culture (typically 1000-1500 spheroids/mL) with representative characteristics of native tumors, such as morphology, proliferation and hypoxia gradients, in a cell-line dependent mode. With the aim of increasing the relevance of spheroids as tumor cell models, several aspects of tumor microenvironment were incorporated, such as the presence of stromal cells (fibroblasts and monocytes) and specific physical parameters, namely by embedding cells in a polymeric matrix. Heterotypic 3D breast and Non-Small Cell Lung Carcinoma (NSCLC) cancer models, based on co-cultures of tumor cells with stromal cells were established by using an alginate matrix to provide physical support to cells. Tumor spheroids were microencapsulated alone or with fibroblasts and monocytes, thus allowing the establishment of an epithelial tumor compartment and a stromal compartment of increasing complexity. Cultures were performed in stirred-tank vessels for 15 days with continuous monitoring. In both breast and lung tumor models, the presence of fibroblasts was associated with secretion of pro-inflammatory cytokines and accumulation of collagen in the microcapsules. Long-term culture (up to 15 days) resulted in phenotypic alterations in co-cultured breast tumor spheroids, such as loss of cell polarity, reduced cell-cell adhesions, collective cell migration and increased angiogenic potential. In contrast, the effects of fibroblasts were not as significant in NSCLC co-cultures using H1650, H1437 and H157 cell lines suggesting that the effect of tumor-stroma cross-talk is cell line dependent. Moreover, these models have also been shown as feasible tools for drug screening by assessing the effect of chemotherapeutic and specific inhibitors compounds on mono- and co-cultures. In conclusion, we have developed scalable, robust and versatile methodologies for the generation and culture of 3D cancer models, enabling long-term in vitro recapitulation of tumor-stroma crosstalk, via reconstruction of key aspects of the tumor microenvironment, allowing continuous monitoring of disease progression events in vitro. In addition, it is easily transferable to industry for feeding high-throughput systems or miniaturized bioreactors used in drug development, target validation and target identification. Acknowledgments: We acknowledge support from the Innovative Medicines Initiative Joint Undertaking (IMI grant agreement n° 115188), resources composed of financial contribution from EU - FP7 and EFPIA companies in kind contribution. iNOVA4Health Research Unit (LISBOA-01-0145-FEDER-007344), which is cofunded by Fundacao para a Ciencia e Tecnologia / Ministerio da Ciencia e do Ensino Superior, through national funds, and by FEDER under the PT2020 Partnership Agreement, is acknowledged. This research has also received support from Fundacao para a Ciencia e Tecnologia, Portugal—PTDC/BBB-BIO/1240/2012. MFE, SA and CP are the recipients of PhD fellowships from FCT (SFRH/BD/52208/2013, PD/BD/105768/2014 and SFRH/BD/52202/2013, respectively). Citation Format: Vitor E Santo, Marta F Estrada, Sofia P Rebelo, Sofia Abreu, Catarina Pinto, Elizabeth Anderson, Wolfgang Sommergruber, Paula Alves, Erwin Boghaert, Catarina Brito. 3D tumor models in bioreactors recapitulate microenvironment and disease progression. [abstract]. In: Proceedings of the AACR Special Conference on Engineering and Physical Sciences in Oncology; 2016 Jun 25-28; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2017;77(2 Suppl):Abstract nr A21." @default.
• W2594150853 created "2017-03-16" @default.
• W2594150853 creator A5013338855 @default.
• W2594150853 creator A5014441247 @default.
• W2594150853 creator A5016707540 @default.
• W2594150853 creator A5021076810 @default.
• W2594150853 creator A5023401505 @default.
• W2594150853 creator A5041615721 @default.
• W2594150853 creator A5047670133 @default.
• W2594150853 creator A5049002384 @default.
• W2594150853 creator A5068992802 @default.
• W2594150853 creator A5075515159 @default.
• W2594150853 date "2017-01-15" @default.
• W2594150853 modified "2023-09-26" @default.
• W2594150853 title "Abstract A21: 3D tumor models in bioreactors recapitulate microenvironment and disease progression" @default.
• W2594150853 doi "https://doi.org/10.1158/1538-7445.epso16-a21" @default.
• W2594150853 hasPublicationYear "2017" @default.
• W2594150853 type Work @default.
• W2594150853 sameAs 2594150853 @default.
• W2594150853 citedByCount "0" @default.
• W2594150853 crossrefType "proceedings-article" @default.
• W2594150853 hasAuthorship W2594150853A5013338855 @default.
• W2594150853 hasAuthorship W2594150853A5014441247 @default.
• W2594150853 hasAuthorship W2594150853A5016707540 @default.
• W2594150853 hasAuthorship W2594150853A5021076810 @default.
• W2594150853 hasAuthorship W2594150853A5023401505 @default.
• W2594150853 hasAuthorship W2594150853A5041615721 @default.
• W2594150853 hasAuthorship W2594150853A5047670133 @default.
• W2594150853 hasAuthorship W2594150853A5049002384 @default.
• W2594150853 hasAuthorship W2594150853A5068992802 @default.
• W2594150853 hasAuthorship W2594150853A5075515159 @default.
• W2594150853 hasConcept C121608353 @default.
• W2594150853 hasConcept C126322002 @default.
• W2594150853 hasConcept C151730666 @default.
• W2594150853 hasConcept C16930146 @default.
• W2594150853 hasConcept C189165786 @default.
• W2594150853 hasConcept C203014093 @default.
• W2594150853 hasConcept C2776107976 @default.
• W2594150853 hasConcept C2779013556 @default.
• W2594150853 hasConcept C2779343474 @default.
• W2594150853 hasConcept C2780394083 @default.
• W2594150853 hasConcept C502942594 @default.
• W2594150853 hasConcept C54355233 @default.
• W2594150853 hasConcept C71924100 @default.
• W2594150853 hasConcept C81885089 @default.
• W2594150853 hasConcept C86803240 @default.
• W2594150853 hasConcept C8891405 @default.
• W2594150853 hasConcept C95444343 @default.
• W2594150853 hasConcept C96232424 @default.
• W2594150853 hasConceptScore W2594150853C121608353 @default.
• W2594150853 hasConceptScore W2594150853C126322002 @default.
• W2594150853 hasConceptScore W2594150853C151730666 @default.
• W2594150853 hasConceptScore W2594150853C16930146 @default.
• W2594150853 hasConceptScore W2594150853C189165786 @default.
• W2594150853 hasConceptScore W2594150853C203014093 @default.
• W2594150853 hasConceptScore W2594150853C2776107976 @default.
• W2594150853 hasConceptScore W2594150853C2779013556 @default.
• W2594150853 hasConceptScore W2594150853C2779343474 @default.
• W2594150853 hasConceptScore W2594150853C2780394083 @default.
• W2594150853 hasConceptScore W2594150853C502942594 @default.
• W2594150853 hasConceptScore W2594150853C54355233 @default.
• W2594150853 hasConceptScore W2594150853C71924100 @default.
• W2594150853 hasConceptScore W2594150853C81885089 @default.
• W2594150853 hasConceptScore W2594150853C86803240 @default.
• W2594150853 hasConceptScore W2594150853C8891405 @default.
• W2594150853 hasConceptScore W2594150853C95444343 @default.
• W2594150853 hasConceptScore W2594150853C96232424 @default.
• W2594150853 hasLocation W25941508531 @default.
• W2594150853 hasOpenAccess W2594150853 @default.
• W2594150853 hasPrimaryLocation W25941508531 @default.
• W2594150853 hasRelatedWork W1609681031 @default.
• W2594150853 hasRelatedWork W2017475678 @default.
• W2594150853 hasRelatedWork W2056075049 @default.
• W2594150853 hasRelatedWork W2174850393 @default.
• W2594150853 hasRelatedWork W2404706513 @default.
• W2594150853 hasRelatedWork W2562290458 @default.
• W2594150853 hasRelatedWork W2563406492 @default.
• W2594150853 hasRelatedWork W2795248085 @default.
• W2594150853 hasRelatedWork W2889903625 @default.
• W2594150853 hasRelatedWork W2924866052 @default.
• W2594150853 hasRelatedWork W2955256400 @default.
• W2594150853 hasRelatedWork W3008998277 @default.
• W2594150853 hasRelatedWork W3010077500 @default.
• W2594150853 hasRelatedWork W3032984816 @default.
• W2594150853 hasRelatedWork W3095092443 @default.
• W2594150853 hasRelatedWork W3108312067 @default.
• W2594150853 hasRelatedWork W3134689510 @default.
• W2594150853 hasRelatedWork W3179275227 @default.
• W2594150853 hasRelatedWork W572985876 @default.
• W2594150853 hasRelatedWork W948260640 @default.
• W2594150853 isParatext "false" @default.
• W2594150853 isRetracted "false" @default.
• W2594150853 magId "2594150853" @default.
• W2594150853 workType "article" @default.